The proposal would eliminate the financial motivation insurers have to mine their members’ charts for additional diagnoses.

Federal officials have a plan that could curb billions of dollars in overpayments to Medicare Advantage plans. But will they ...

By Patrick Wingrove Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the ...

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on drugs cleared under a new plan to slash FDA drug review times.

More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new ...

This story was produced by the State College regional bureau of Spotlight PA, an independent, nonpartisan newsroom dedicated to investigative and public-service ...

In recent years, GLP-1 (glucagon-like peptide-1) medications have gained considerable attention as effective treatments for weight loss and metabolic health. These medications mimic the action of the ...